Cambridge, Mass.-based InVivo Therapeutics will present at the 2016 Tissue Engineering & Regenerative Medicine International Society Americas conference, held in San Diego between Dec. 11 and Dec. 14, 2016.
Here are five notes:
1. Artem Kutikov, PhD, will deliver the presentation on the abstract, "Demonstration of a Proof-of-Concept Device for Delivering Bioengineered Neural Stem Cell Trails to the Spinal Cord."
2. Richard Layer, PhD, Simon Moore, PhD, Alex Aimetti, PhD, Christoph Hofstetter, MD, PhD, James Guest, MD, PhD, and Thomas Ulich, MD, co-authored the paper alongside Dr. Kutikov.
3. InVivo CEO and Chairman Mark Perrin said the abstract illustrates the validation of the TrailMaker, a proof-of-concept device creating longitudinal cellular transplants in the spinal cords of animal models.
4. The TrailMaker is only for preclinical use, right now.
5. Mr. Perrin noted the "prototype device will inform and enable the design of the next-generation device that we hope to study in the clinic in order to help those with chronic spinal cord injuries."